The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tacnet-Delorme, P.
Right arrow Articles by Arlaud, G. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tacnet-Delorme, P.
Right arrow Articles by Arlaud, G. J.
The Journal of Immunology, 2001, 167: 6374-6381.
Copyright © 2001 by The American Association of Immunologists

{beta}-Amyloid Fibrils Activate the C1 Complex of Complement Under Physiological Conditions: Evidence for a Binding Site for A{beta} on the C1q Globular Regions1

Pascale Tacnet-Delorme, Sylvie Chevallier and Gérard J. Arlaud2

Laboratoire d’Enzymologie Moléculaire, Institut de Biologie Structurale, Grenoble, France

Previous studies based on the use of serum as a source of C have shown that fibrils of {beta}-amyloid peptides that accumulate in the brain of patients with Alzheimer’s disease have the ability to bind C1q and activate the classical C pathway. The objective of the present work was to test the ability of fibrils of peptide A{beta}1–42 to trigger direct activation of the C1 complex and to carry out further investigations on the site(s) of C1q involved in the interaction with A{beta}1–42. Using C1 reconstituted from purified C1q, C1r, and C1s, it was shown that A{beta}1–42 fibrils trigger direct C1 activation both in the absence of C1 inhibitor and at C1 inhibitor:C1 ratios up to 8:0, i.e., under conditions consistent with the physiological context in serum. The truncated peptide A{beta}12–42 and the double mutant (D7N, E11Q) of A{beta}1–42 did not yield C1 activation, providing further evidence that the C1 binding site of {beta}-amyloid fibrils is located in the acidic N-terminal 1–11 region of the A{beta}1–42 peptide. Binding studies performed using a solid phase assay provided strong evidence that C1q interacts with A{beta}1–42 fibrils through its C-terminal globular regions. In contrast to previous studies based on a different experimental design, no significant involvement of the C1q collagen-like domain was detected. These findings were confirmed by additional experiments based on C1 activation and C4 consumption assays. These observations provide direct evidence of the ability of {beta}-amyloid fibrils to trigger activation of the classical C pathway and further support the hypothesis that C activation may be a component of the pathogenesis of Alzheimer’s disease.




This article has been cited by other articles:


Home page
J. Immunol.Home page
A. Flores-Langarica, Y. Sebti, D. A. Mitchell, R. B. Sim, and G. G. MacPherson
Scrapie Pathogenesis: The Role of Complement C1q in Scrapie Agent Uptake by Conventional Dendritic Cells
J. Immunol., February 1, 2009; 182(3): 1305 - 1313.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
E. Herczenik and M. F. B. G. Gebbink
Molecular and cellular aspects of protein misfolding and disease
FASEB J, July 1, 2008; 22(7): 2115 - 2133.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Paidassi, P. Tacnet-Delorme, V. Garlatti, C. Darnault, B. Ghebrehiwet, C. Gaboriaud, G. J. Arlaud, and P. Frachet
C1q Binds Phosphatidylserine and Likely Acts as a Multiligand-Bridging Molecule in Apoptotic Cell Recognition
J. Immunol., February 15, 2008; 180(4): 2329 - 2338.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. D. G. McGrath, M. C. Brouwer, G. J. Arlaud, M. R. Daha, C. E. Hack, and A. Roos
Evidence That Complement Protein C1q Interacts with C-Reactive Protein through Its Globular Head Region.
J. Immunol., March 1, 2006; 176(5): 2950 - 2957.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Rossi, F. Teillet, N. M. Thielens, I. Bally, and G. J. Arlaud
Functional Characterization of Complement Proteases C1s/Mannan-binding Lectin-associated Serine Protease-2 (MASP-2) Chimeras Reveals the Higher C4 Recognition Efficacy of the MASP-2 Complement Control Protein Modules
J. Biol. Chem., December 23, 2005; 280(51): 41811 - 41818.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Gaboriaud, J. Juanhuix, A. Gruez, M. Lacroix, C. Darnault, D. Pignol, D. Verger, J. C. Fontecilla-Camps, and G. J. Arlaud
The Crystal Structure of the Globular Head of Complement Protein C1q Provides a Basis for Its Versatile Recognition Properties
J. Biol. Chem., November 21, 2003; 278(47): 46974 - 46982.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
U. Kishore, S. K. Gupta, M. V. Perdikoulis, M. S. Kojouharova, B. C. Urban, and K. B. M. Reid
Modular Organization of the Carboxyl-Terminal, Globular Head Region of Human C1q A, B, and C Chains
J. Immunol., July 15, 2003; 171(2): 812 - 820.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.